Modes of action of Freund's adjuvants in experimental models of autoimmune diseases.
about
Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-gammaAdjuvants: Classification, Modus Operandi, and LicensingCerebral biochemical pathways in experimental autoimmune encephalomyelitis and adjuvant arthritis: a comparative metabolomic studyLive Imaging of Immune Responses in Experimental Models of Multiple SclerosisAutoimmune encephalitis in humans: how closely does it reflect multiple sclerosis ?Extracellular matrix from porcine small intestinal submucosa (SIS) as immune adjuvantsAn H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virus.High gene expression of inflammatory markers and IL-17A correlates with severity of injection site reactions of Atlantic salmon vaccinated with oil-adjuvanted vaccines.T-cell activation promotes tumorigenesis in inflammation-associated cancer.The inhibitory effect against collagen-induced arthritis by Schistosoma japonicum infection is infection stage-dependent.Suppression of NFAT5-mediated Inflammation and Chronic Arthritis by Novel κB-binding Inhibitors.Complete Freund's adjuvant induces experimental autoimmune myocarditis by enhancing IL-6 production during initiation of the immune responseBystander activation of irrelevant CD4+ T cells following antigen-specific vaccination occurs in the presence and absence of adjuvant.Aberrant muscle antigen exposure in mice is sufficient to cause myositis in a Treg cell-deficient milieuIn vivo immunogenicity of Tax(11-19) epitope in HLA-A2/DTR transgenic mice: implication for dendritic cell-based anti-HTLV-1 vaccineRegulatory T cell frequencies and phenotypes following anti-viral vaccination.Alternatives to mineral oil adjuvants in vaccines against Aeromonas salmonicida subsp. salmonicida in rainbow trout offer reductions in adverse effectsToll-like receptor 4 is involved in inflammatory and joint destructive pathways in collagen-induced arthritis in DBA1J mice.Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin MincleIn vivo adsorption of autoantibodies in myasthenia gravis using Nanodisc-incorporated acetylcholine receptor.CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination.Atheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccineCombinatorial contextualization of peptidic epitopes for enhanced cellular immunity.Induction of protective anti-CTL epitope responses against HER-2-positive breast cancer based on multivalent T7 phage nanoparticles.Role of tachykinin 1 and 4 gene-derived neuropeptides and the neurokinin 1 receptor in adjuvant-induced chronic arthritis of the mouseAnti-inflammatory and antiarthritic activity of anthraquinone derivatives in rodentsInfection-triggered regulatory mechanisms override the role of STAT 4 in control of the immune response to influenza virus antigens.The critical role of leukotriene B4 in antigen-induced mechanical hyperalgesia in immunised rats.Effects of early IL-17A neutralization on disease induction in a primate model of experimental autoimmune encephalomyelitis.Association between neuromyelitis optica and tuberculosis in a Chinese population.The role of TLR4 activation in photoreceptor mitochondrial oxidative stressImmune response to Chlamydophila abortus POMP91B protein in the context of different Pathogen Associated Molecular Patterns (PAMP); role of antigen in the orientation of immune response.Autoimmunity to the alpha 3 chain of type IV collagen in glomerulonephritis is triggered by 'autoantigen complementarity'.Discrepant effects of human interferon-gamma on clinical and immunological disease parameters in a novel marmoset model for multiple sclerosis.Genetic analysis of the influence of neuroantigen-complete Freund's adjuvant emulsion structures on the sexual dimorphism and susceptibility to experimental allergic encephalomyelitisNeurodegeneration in Autoimmune Optic Neuritis Is Associated with Altered APP Cleavage in Neurons and Up-Regulation of p53Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae KeratitisIn vivo imaging of lymphatic vessels in development, wound healing, inflammation, and tumor metastasis.Immune profile of an atypical EAE model in marmoset monkeys immunized with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund's adjuvantActive immunization with human interleukin-15 induces neutralizing antibodies in non-human primates.
P2860
Q24804229-5B5A3B6E-F890-422E-989D-4DE700372BF3Q26747586-5E9A5E1C-1967-4376-8B8A-B4DD2196600EQ27315145-57CE8D4A-B886-47EC-8F41-7ECAEA3B4098Q28075478-1EFCA945-9E6D-4872-8D07-5629B6DDE184Q28270642-D3065AF3-80FC-4385-B4A1-5EF5F622FB3CQ28743077-67FF11C6-84A4-467D-B964-D0CA0FA7863FQ30375268-B25B70DE-E321-4813-9874-F79A413EB45DQ33589516-34E08C7E-7AC4-4DB7-8FDF-B62A407A752EQ33590130-CAC53321-AD8C-4CF7-BF08-CD0BDBB9E663Q33600341-39FBF6C1-E465-40CF-8504-11914461FE87Q33603679-5FB6BD28-BA34-4E4B-8B97-FCFBD094B21DQ33638740-49F39C76-0855-4C15-B766-63ED1BDDF944Q33658057-66E1EFE0-3B5B-4C47-B0E9-9F79287C21B1Q33661671-C138704E-3BC9-4F94-B336-AC97987C0FC0Q33709237-B9D1163C-3682-4A33-9788-D47C483E83EFQ33848515-E40ED3FB-89AA-43F7-9B17-A3460A494267Q33918586-EA3E4DF6-DAD6-4C4D-8303-B81DB1A4F4DFQ33999768-99D6D561-AEE9-42D9-B513-83AF1819F9ACQ34087974-835C5FB2-2890-49E9-A794-823C69AD664BQ34127035-12AF7716-B03A-4B87-BF26-600C380F9721Q34234563-B5A377F5-D19E-42AE-AB9B-C7EE8C726822Q34238712-DE5736BE-48BD-4F1A-8B8E-92BF2240EADAQ34400527-3C3A632E-32AD-411D-91B5-1C7564817029Q34482487-6A420071-E3FC-466D-9C1F-08668E8FCF30Q34692273-788F1D17-7AE1-46D4-9F28-B6057B36BD4AQ34907832-831C04FC-A9F7-4B84-B816-0F93AA2D194BQ34976848-27DCC6A4-EAEA-430E-BDCC-70AD4255FC5CQ35045518-60B1862C-AEAB-4B89-9BC5-072EAEF33BE7Q35082644-DB359E45-B9BD-47FD-A976-1787F65543BAQ35098917-9D7ADB3E-0097-4CC1-B471-235D943CE513Q35221444-E996140E-7DCC-496A-BF3C-0484478E097BQ35458412-EFA751B7-7458-42D2-A798-A8B9715724B4Q35695000-6A76EEA3-9212-4F7B-8064-F8A7E3E704D8Q35759597-BAE9C855-DFE7-4DFF-BDF3-3D5CABA10DD1Q35792047-54B2F40F-FEEB-42EC-8F16-C02E46D47F14Q35794898-8E9ABCFC-35DA-4577-BC6F-A51B7A78E726Q35826641-A4529925-6EA5-4589-A45F-389FC4379126Q35924996-A4FD79B4-45C6-49E8-A3C0-E0B40F404EA7Q36071018-9E867579-7B9D-4B67-B1DA-DEB66BE8C0E1Q36145575-BE65B7B9-C711-44BB-9DF2-3FFAE80827A0
P2860
Modes of action of Freund's adjuvants in experimental models of autoimmune diseases.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Modes of action of Freund's adjuvants in experimental models of autoimmune diseases.
@ast
Modes of action of Freund's adjuvants in experimental models of autoimmune diseases.
@en
Modes of action of Freund's adjuvants in experimental models of autoimmune diseases.
@nl
type
label
Modes of action of Freund's adjuvants in experimental models of autoimmune diseases.
@ast
Modes of action of Freund's adjuvants in experimental models of autoimmune diseases.
@en
Modes of action of Freund's adjuvants in experimental models of autoimmune diseases.
@nl
prefLabel
Modes of action of Freund's adjuvants in experimental models of autoimmune diseases.
@ast
Modes of action of Freund's adjuvants in experimental models of autoimmune diseases.
@en
Modes of action of Freund's adjuvants in experimental models of autoimmune diseases.
@nl
P1476
Modes of action of Freund's adjuvants in experimental models of autoimmune diseases.
@en
P2093
P304
P577
2001-12-01T00:00:00Z